These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 39050827)

  • 1. Association Between Rhesus and ABO Blood Group Types and Their Impact on Clinical Outcomes in Critically Ill Patients with COVID-19: A Multi-Center Investigation.
    Al Sulaiman K; Aljuhani O; Korayem GB; AlFaifi M; Alharthi AF; Alshehri A; Alaboud MS; Alzahrani IS; Alenazi BA; Alanazi FF; Alrashidi H; Alotaibi SM; Aloufi K; Alotaibi RM; Alalawi M; Altebainawi AF; Alshami MY; Alenazi AA; Abalkhail GA; Bin Naheet R; Alnasr RMA; Alrashed M; Al Mutairi FE; Albarqi KJ; Alshammari RS; Abunayyan NM; Aldhmadi WJ; Vishwakarma R
    Infect Drug Resist; 2024; 17():3161-3171. PubMed ID: 39050827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When antivirals backfire: An evaluation of favipiravir's clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study.
    Al Sulaiman K; Aljuhani O; Korayem GB; Altebainawi AF; AlFaifi M; Nahari M; Almagthali A; Thabit AK; Alhajaji R; Alharbi R; Kahtani K; Alenazi AA; Alharbi A; Alghwainm MM; Alotaibi SM; Alghamdi YS; Alotaibi S; Alonazi SH; Almutairi JM; Vishwakarma R
    J Infect Public Health; 2023 Sep; 16(9):1492-1499. PubMed ID: 37355406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Early Tocilizumab Effect on Multiorgan Dysfunction in Critically Ill Patients With COVID-19: A Propensity Score-Matched Study.
    Aljuhani O; Korayem GB; Altebainawi AF; Al Harthi A; Badreldin HA; Alsalloum MA; Eljaaly K; Alharbi A; Aljehani R; Vishwakarma R; Alenazi AA; Alalawi M; Alissa A; Al Aamer K; Al Enazi H; Almusallam M; Alshehri A; Bukhari R; Alasmari G; AlQahtani MM; Al Shammari S; Alsulaymi HO; Al Sulaiman K
    J Intensive Care Med; 2023 Jun; 38(6):534-543. PubMed ID: 36683420
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically lll Patients with COVID-19: A Multicenter Cohort Study - New-Onset Atrial Fibrillation and COVID-19.
    Kensara R; Aljuhani O; Korayem GB; Alkofide H; Almohareb SN; Alosaimi YS; Altebainawi AF; Bin Saleh K; Andas NA; Harbi SA; Harthi AFA; Ashkan U; Alghamdi R; Badreldin HA; Hafiz A; AlFaifi M; Alqahtani RA; Vishwakarma R; Alenazi AA; Alalawi M; Mahboob R; Alfouzan RA; Al Tuhayni LB; Qahtani NA; Sulaiman KA
    Clin Appl Thromb Hemost; 2023; 29():10760296231156178. PubMed ID: 36789786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Dexamethasone and Delirium in Critically Ill Patients: A Retrospective Cohort Study of a Large Clinical Database.
    Wu Z; Li H; Liao K; Wang Y
    J Surg Res; 2021 Jul; 263():89-101. PubMed ID: 33639374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study.
    Al Sulaiman K; Aljuhani O; Korayem GB; Hafiz A; Alalawi M; Badreldin HA; Altebainawi AF; Vishwakarma R; Alissa A; Alghamdi A; Alenazi AA; Al Enazi H; Alanazi S; Alhammad A; Alghamdi J; AlFaifi M; Al Sehli FA; Aldossari MA; Alhubaishi AA; Al-Ali AY; Al-Dorzi HM
    Thromb J; 2022 Dec; 20(1):74. PubMed ID: 36482388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketamine-based Sedation Use in Mechanically Ventilated Critically Ill Patients with COVID-19: A Multicenter Cohort Study.
    Aljuhani O; Al Sulaiman K; Korayem GB; Altebainawi AF; Alshaya A; Nahari M; Alsamnan K; Alkathiri MA; Al-Dosari BS; Alenazi AA; Alsohimi S; Alnajjar LI; Alfaifi M; AlQussair N; Alanazi RM; Alhmoud MF; Alanazi NL; Alkofide H; Alenezi AM; Vishwakarma R
    Saudi Pharm J; 2024 May; 32(5):102061. PubMed ID: 38596319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival implications vs. complications: unraveling the impact of vitamin D adjunctive use in critically ill patients with COVID-19-A multicenter cohort study.
    Al Sulaiman K; Korayem GB; Aljuhani O; Altebainawi AF; Shawaqfeh MS; Alarfaj SJ; Alharbi RA; Ageeli MM; Alissa A; Vishwakarma R; Ibrahim A; Alenazi AA; Alghnam S; Alshehri N; Alshammari MM; Alhubaishi A; Aldhaeefi M; Alamri FF; Syed Y; Khan R; Alalawi M; Alanazi KA; Alresayes FS; Albarqi KJ; Al Ghamdi G
    Front Med (Lausanne); 2023; 10():1237903. PubMed ID: 37692775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study.
    Al Harthi AF; Aljuhani O; Korayem GB; Altebainawi AF; Alenezi RS; Al Harbi S; Gramish J; Kensara R; Hafidh A; Al Enazi H; Alawad A; Alotaibi R; Alshehri A; Alhuthaili O; Vishwakarma R; Bin Saleh K; Alsulaiman T; Alqahtani RA; Hussain S; Almazrou S; Al Sulaiman K
    J Intensive Care Med; 2022 Sep; 37(9):1238-1249. PubMed ID: 35450493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO blood group and rhesus factor association with inpatient COVID-19 mortality and severity: a two-year retrospective review.
    Phan AT; Ucar AA; Malkoc A; Hu J; Buxton L; Tseng AW; Dong F; Nguyễn JPT; Modi AP; Deshpande O; Lay J; Ku A; Ogunyemi D; Arabian S
    Blood Res; 2023 Sep; 58(3):138-144. PubMed ID: 37751922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched study.
    Al Sulaiman K; Aljuhani O; Al Shaya AI; Kharbosh A; Kensara R; Al Guwairy A; Alharbi A; Algarni R; Al Harbi S; Vishwakarma R; Korayem GB
    Crit Care; 2021 Oct; 25(1):363. PubMed ID: 34663411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.
    Al Sulaiman K; Korayem GB; Altebainawi AF; Al Harbi S; Alissa A; Alharthi A; Kensara R; Alfahed A; Vishwakarma R; Al Haji H; Almohaimid N; Al Zumai O; Alrubayan F; Asiri A; Alkahtani N; Alolayan A; Alsohimi S; Melibari N; Almagthali A; Aljahdali S; Alenazi AA; Alsaeedi AS; Al Ghamdi G; Al Faris O; Alqahtani J; Al Qahtani J; Alshammari KA; Alshammari KI; Aljuhani O
    Crit Care; 2022 Oct; 26(1):304. PubMed ID: 36192801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxycycline's Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study.
    Al Sulaiman K; Aljuhani O; Korayem GB; Alnajjar LI; Altebainawi AF; AlFaifi M; Vishwakarma R; Alenazi AA; Alalawi M; Alissa A; Alsowaida YS; Alsohimi S; Almagthali A; Alay SM; Altaher N; Alamri MG; Alangari D; Alzahrani A; Abdul Razack HI; Alhamoud J; Alshaya A; Gramish J; Al Aamer K; Alsaeedi AS; Alghamdi G
    Clin Appl Thromb Hemost; 2023; 29():10760296231177017. PubMed ID: 37322869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between standard Vs. Escalated dose venous thromboembolism (VTE) prophylaxis in critically ill patients with COVID-19: A two centers, observational study.
    Aljuhani O; Al Sulaiman K; Hafiz A; Eljaaly K; Alharbi A; Algarni R; Al Homaid S; Kahtani K; Alsulaiman T; Vishwakarma R; Al Ghamdi G; Alalawi M; Korayem GB
    Saudi Pharm J; 2022 Apr; 30(4):398-406. PubMed ID: 35136364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early versus late tracheostomy in critically ill COVID-19 patients.
    Szafran A; Dahms K; Ansems K; Skoetz N; Monsef I; Breuer T; Benstoem C
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD015532. PubMed ID: 37982427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness : A Population-Based Cohort Study.
    Ray JG; Schull MJ; Vermeulen MJ; Park AL
    Ann Intern Med; 2021 Mar; 174(3):308-315. PubMed ID: 33226859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study.
    Al Sulaiman K; Aljuhani O; Korayem GB; Altebainawi AF; Vishwakarma R; AlFaifi M; Alsohimi S; Alrayes A; Albishi S; Alqahtani R; Alalawi M; Al Sulaihim I; Alanazi TA; Alqahtani RA; Almagthali A; Jomah S; Alshlowi A; Alshammari TR; Alzahrani SS; Abdulqader MI
    Clin Appl Thromb Hemost; 2023; 29():10760296231218216. PubMed ID: 38073058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between tocilizumab therapy and the development of thrombosis in critically ill patients with COVID-19: a multicenter, cohort study.
    Aljuhani O; Al Sulaiman K; Korayem GB; Altebainawi AF; Alsohimi S; Alqahtani R; Alfaifi S; Alharbi A; AlKhayrat A; Hattan A; Albassam M; Almohammed OA; Alkeraidees A; Alonazi DA; Alsalman WF; Aldamegh G; Alshahrani R; Vishwakarma R
    Sci Rep; 2024 Feb; 14(1):3037. PubMed ID: 38321099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of non-COVID-19 critically ill patients during the COVID-19 pandemic : A retrospective propensity score-matched analysis.
    Bologheanu R; Maleczek M; Laxar D; Kimberger O
    Wien Klin Wochenschr; 2021 Sep; 133(17-18):942-950. PubMed ID: 33909109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ABO blood groups on length of hospital stay according to age in Covid-19 patients.
    Gursoy V; Avci S
    Hematol Transfus Cell Ther; 2022; 44(1):7-12. PubMed ID: 34870100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.